35 minutes | Oct 27th 2020

Lynn Seely On Raising $1 Billion To Redefine Care For Women And Men

Play
Like
Play Next
Mark Played
Lynn Seely started Myovant Sciences which delivers innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market. The company has raised $1 billion from investors such as Danippon Sumitomo Pharma. Myovant Sciences was one of the largest biopharma IPOs in 2016.
Play
Like
Play Next
Mark Played